Dr. Scott Gottlieb Says Paxlovid's Rebound Could Be Because Doctor's are Prescribing it too Early

"That's not necessarily how the drug was studied. The drug was studied for people who had been symptomatic for 3 days on average. So the people in the clinical trial had started to mount an immune response."